ROMEE GANDHI: Open Payments
NPI 1407227408 · CLARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,166 in 86 payments from 14 companies in 2025. Trend: 2023 $759 · 2024 $1,354 · 2025 $1,166
Food & beverage: $1,166
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 7 | $184 |
| MAYNE PHARMA COMMERCIAL LLC | 12 | $161 |
| PFIZER INC. | 13 | $156 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 18 | $148 |
| Incyte Corporation | 11 | $139 |
| Organon LLC | 7 | $76 |
| Regeneron Healthcare Solutions, Inc. | 4 | $68 |
| Galderma Laboratories, L.P. | 3 | $49 |
| LEO Pharma Inc. | 3 | $48 |
| Botanix SB Inc | 3 | $45 |
Products named: OTEZLA, OPZELURA, Winlevi, CIBINQO, VTAMA, LITFULO, DUPIXENT, ANZUPGO.
Industry payments across NJ — which companies pay providers there.
